ARTICLE | Management Tracks
Cherrington to be chair at Actym, Stutz joins as CBO
Plus Krishnan leaves Arcus and updates from Invectys, Sawai and West
May 14, 2022 12:02 AM UTC
Actym Therapeutics Inc. named Julie Cherrington as chair, James Stutz as CBO and Omkar Joshi as VP of technical operations. Cherrington was president and CEO of QUE Oncology Inc., Arch Oncology Inc., Revitope Oncology Inc., Zenith Epigenetics Ltd., and Pathway Therapeutics Inc. Stutz was VP and head of business development of Instil Bio Inc. (NASDAQ:TIL), CFO of Tolerion Inc. and CBO of Tioma Therapeutics Inc.
Arcus Biosciences Inc. (NYSE:RCUS) said it was looking for a new CMO after Kartik Krishnan left in April. Krishnan joined the oncology company as VP of clinical development in 2019 and became CMO in November 2021. The company said the new CMO would oversee six clinical programs...